stoxline Quote Chart Rank Option Currency Glossary
Genprex, Inc. (GNPX)
0.237  -0.005 (-2.07%)    12-01 16:00
Open: 0.2585
High: 0.2585
Volume: 109,107
Pre. Close: 0.242
Low: 0.2265
Market Cap: 14(M)
Technical analysis
2023-12-01 4:20:16 PM
Short term     
Mid term     
Targets 6-month :  0.35 1-year :  0.43
Resists First :  0.3 Second :  0.37
Pivot price 0.24
Supports First :  0.18 Second :  0.15
MAs MA(5) :  0.24 MA(20) :  0.25
MA(100) :  0.45 MA(250) :  0.82
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  32.9 D(3) :  26.2
RSI RSI(14): 43.6
52-week High :  1.94 Low :  0.18
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ GNPX ] has closed above bottom band by 35.0%. Bollinger Bands are 70.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.26 - 0.26 0.26 - 0.26
Low: 0.22 - 0.22 0.22 - 0.23
Close: 0.23 - 0.24 0.24 - 0.24
Company Description

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

Headline News

Wed, 29 Nov 2023
Is Genprex Inc (GNPX) Stock a Bad Value? - InvestorsObserver

Thu, 23 Nov 2023
Genprex Granted Orphan Drug Designation in Small Cell Lung Cancer - Yahoo Finance

Fri, 17 Nov 2023
North American Morning Briefing: Stock Futures -2- - Morningstar

Wed, 04 Oct 2023
Genprex to Present Data on the Use of REQORSA® for the ... - PR Newswire

Thu, 21 Sep 2023
Genprex Inc. (NASDAQ: GNPX) Receives Orphan Drug Designation ... - BioSpace

Mon, 04 Sep 2023
GENPREX (GNPX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 59 (M)
Shares Float 59 (M)
Held by Insiders 2.3 (%)
Held by Institutions 15.8 (%)
Shares Short 1,640 (K)
Shares Short P.Month 1,650 (K)
Stock Financials
EPS -0.62
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.2
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -85 %
Return on Equity (ttm) -158.1 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.54
Qtrly Earnings Growth 0 %
Operating Cash Flow -24 (M)
Levered Free Cash Flow -12 (M)
Stock Valuations
PE Ratio -0.39
PEG Ratio 0
Price to Book value 1.12
Price to Sales 0
Price to Cash Flow -0.58
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android